$5.34
-0.40 (-6.97%)
Open$5.70
Previous Close$5.74
Day High$5.71
Day Low$5.34
52W High$6.92
52W Low$4.91
Volume—
Avg Volume146.3K
Market Cap35.98M
P/E Ratio—
EPS$-9.35
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+226.6% upside
Current
$5.34
$5.34
Target
$17.44
$17.44
$9.95
$17.44 avg
$18.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.12M | 21.13M | 21.81M |
| Net Income | -133,172,516 | -3,613,419 | -4,862,244 |
| Profit Margin | -661.9% | -17.1% | -22.3% |
| EBITDA | -139,029,659 | -5,916,348 | -5,182,437 |
| Free Cash Flow | — | -5,168,786 | -3,508,220 |
| Rev Growth | +692.3% | -1.2% | +1.1% |
| Debt/Equity | — | 0.72 | 0.63 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.29 | -1.12% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $423.64 | +1.32% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $151.28 | -0.61% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $526.73 | -0.18% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $750.51 | -0.23% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $254.07 | -0.51% | 41.4 | 33.44B |